PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1997; 90(Suppl 31): 47–58.
PMCID: PMC1296099

Management of cystic fibrosis before and after lung transplantation.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Madden BP, Hodson ME, Tsang V, Radley-Smith R, Khaghani A, Yacoub MY. Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet. 1992 Jun 27;339(8809):1583–1587. [PubMed]
  • Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report--1996. J Heart Lung Transplant. 1996 Jul;15(7):655–674. [PubMed]
  • Abbott J, Dodd M, Webb AK. Different perceptions of disease severity and self care between patients with cystic fibrosis, their close companions, and physician. Thorax. 1995 Jul;50(7):794–796. [PMC free article] [PubMed]
  • Nelson JW, Butler SL, Krieg D, Govan JR. Virulence factors of Burkholderia cepacia. FEMS Immunol Med Microbiol. 1994 Feb;8(2):89–97. [PubMed]
  • Dennis CM, McNeil KD, Dunning J, Stewart S, Friend PJ, Alexander G, Higenbottam TW, Calne RY, Wallwork J. Heart-lung-liver transplantation. J Heart Lung Transplant. 1996 May;15(5):536–538. [PubMed]
  • Corey M, McLaughlin FJ, Williams M, Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J Clin Epidemiol. 1988;41(6):583–591. [PubMed]
  • Naon H, Hack S, Shelton MT, Gotthoffer RC, Gozal D. Resting energy expenditure. Evolution during antibiotic treatment for pulmonary exacerbation in cystic fibrosis. Chest. 1993 Jun;103(6):1819–1825. [PubMed]
  • Dennis C, Caine N, Sharples L, Smyth R, Higenbottam T, Stewart S, Wreghitt T, Large S, Wells FC, Wallwork J. Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant. 1993 Nov-Dec;12(6 Pt 1):893–902. [PubMed]
  • Elborn JS, Jagoe T, Shale DJ. Metabolic and respiratory consequences of a glucose load in a hypoxic patient with cystic fibrosis. Ulster Med J. 1992 Oct;61(2):188–192. [PMC free article] [PubMed]
  • Hodson ME, Madden BP, Steven MH, Tsang VT, Yacoub MH. Non-invasive mechanical ventilation for cystic fibrosis patients--a potential bridge to transplantation. Eur Respir J. 1991 May;4(5):524–527. [PubMed]
  • Piper AJ, Parker S, Torzillo PJ, Sullivan CE, Bye PT. Nocturnal nasal IPPV stabilizes patients with cystic fibrosis and hypercapnic respiratory failure. Chest. 1992 Sep;102(3):846–850. [PubMed]
  • Stead RJ, Davidson TI, Duncan FR, Hodson ME, Batten JC. Use of a totally implantable system for venous access in cystic fibrosis. Thorax. 1987 Feb;42(2):149–150. [PMC free article] [PubMed]
  • Snell GI, de Hoyos A, Krajden M, Winton T, Maurer JR. Pseudomonas cepacia in lung transplant recipients with cystic fibrosis. Chest. 1993 Feb;103(2):466–471. [PubMed]
  • Ramirez JC, Patterson GA, Winton TL, de Hoyos AL, Miller JD, Maurer JR. Bilateral lung transplantation for cystic fibrosis. The Toronto Lung Transplant Group. J Thorac Cardiovasc Surg. 1992 Feb;103(2):287–294. [PubMed]
  • Yamagishi Y, Fujita J, Takigawa K, Negayama K, Nakazawa T, Takahara J. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest. 1993 Jun;103(6):1706–1709. [PubMed]
  • Egan JJ, Chadwick P, Lowe L, Woodcock AA. The potential of nosocomial transmission of Pseudomonas cepacia exists at cardiopulmonary transplant centers. Chest. 1994 May;105(5):1630–1631. [PubMed]
  • Flume PA, Egan TM, Paradowski LJ, Detterbeck FC, Thompson JT, Yankaskas JR. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med. 1994 Jun;149(6):1601–1607. [PubMed]
  • Egan JJ, McNeil K, Bookless B, Gould K, Corris P, Higenbottam T, Webb AK, Woodcock AA. Post-transplantation survival of cystic fibrosis patients infected with Pseudomonas cepacia. Lancet. 1994 Aug 20;344(8921):552–553. [PubMed]
  • Ryan PJ, Stableforth DE. Referral for lung transplantation: experience of a Birmingham Adult Cystic Fibrosis Centre between 1987 and 1994. Thorax. 1996 Mar;51(3):302–305. [PMC free article] [PubMed]
  • Shaw D, Poxton IR, Govan JR. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol Med Microbiol. 1995 Apr;11(2):99–106. [PubMed]
  • Kramer MR, Denning DW, Marshall SE, Ross DJ, Berry G, Lewiston NJ, Stevens DA, Theodore J. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):552–556. [PubMed]
  • Tazelaar HD, Baird AM, Mill M, Grimes MM, Schulman LL, Smith CR. Bronchocentric mycosis occurring in transplant recipients. Chest. 1989 Jul;96(1):92–95. [PubMed]
  • Yacoub MH, Banner NR, Khaghani A, Fitzgerald M, Madden B, Tsang V, Radley-Smith R, Hodson M. Heart-lung transplantation for cystic fibrosis and subsequent domino heart transplantation. J Heart Transplant. 1990 Sep-Oct;9(5):459–467. [PubMed]
  • Au J, Hawkins T, Venables C, Morritt G, Scott CD, Gascoigne AD, Corris PA, Hilton CJ, Dark JH. Upper gastrointestinal dysmotility in heart-lung transplant recipients. Ann Thorac Surg. 1993 Jan;55(1):94–97. [PubMed]
  • Koretz RL. Nutritional supplementation in the ICU. How critical is nutrition for the critically ill? Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):570–573. [PubMed]
  • Bonnefoy-Berard N, Revillard JP. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J Heart Lung Transplant. 1996 May;15(5):435–442. [PubMed]
  • Halloran PF. Molecular mechanisms of new immunosuppressants. Clin Transplant. 1996 Feb;10(1 Pt 2):118–123. [PubMed]
  • Kahan BD. Cyclosporine. N Engl J Med. 1989 Dec 21;321(25):1725–1738. [PubMed]
  • Kovarik JM, Mueller EA, van Bree JB, Flückiger SS, Lange H, Schmidt B, Boesken WH, Lison AE, Kutz K. Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients. Transplantation. 1994 Sep 27;58(6):658–663. [PubMed]
  • Gennery A, O'Sullivan J, O'Brien C, Dark J. Which cyclosporin formulation? Lancet. 1996 Oct 26;348(9035):1177–1177. [PubMed]
  • Trulock EP, Ettinger NA, Brunt EM, Pasque MK, Kaiser LR, Cooper JD. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest. 1992 Oct;102(4):1049–1054. [PubMed]
  • Herve P, Silbert D, Cerrina J, Simonneau G, Dartevelle P. Impairment of bronchial mucociliary clearance in long-term survivors of heart/lung and double-lung transplantation. The Paris-Sud Lung Transplant Group. Chest. 1993 Jan;103(1):59–63. [PubMed]
  • Norman DJ, Shield CF, 3rd, Henell KR, Kimball J, Barry JM, Bennett WM, Leone M. Effectiveness of a second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection. Transplantation. 1988 Oct;46(4):523–529. [PubMed]
  • Egan JJ, Barber L, Lomax J, Fox A, Yonan N, Rahman AN, Campbell CS, Deiraniya AK, Carroll KB, Craske J, et al. Detection of human cytomegalovirus antigenaemia: a rapid diagnostic technique for predicting cytomegalovirus infection/pneumonitis in lung and heart transplant recipients. Thorax. 1995 Jan;50(1):9–13. [PMC free article] [PubMed]
  • Armitage JM, Kormos RL, Stuart RS, Fricker FJ, Griffith BP, Nalesnik M, Hardesty RL, Dummer JS. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression. J Heart Lung Transplant. 1991 Nov-Dec;10(6):877–887. [PubMed]
  • Egan J, Stewart J, Yonan N, Arrand J, Woodcock A. Non-Hodgkin lymphoma in heart/lung transplant recipients. Lancet. 1994 Feb 19;343(8895):481–481. [PubMed]
  • Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet. 1993 Dec 18;342(8886-8887):1514–1516. [PubMed]
  • Egan JJ, Hasleton PS, Yonan N, Rahman AN, Deiraniya AK, Carroll KB, Woodcock AA. Necrotic, ulcerative bronchitis, the presenting feature of lymphoproliferative disease following heart-lung transplantation. Thorax. 1995 Feb;50(2):205–207. [PMC free article] [PubMed]
  • Cooper JD, Billingham M, Egan T, Hertz MI, Higenbottam T, Lynch J, Mauer J, Paradis I, Patterson GA, Smith C, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993 Sep-Oct;12(5):713–716. [PubMed]
  • Patterson GM, Wilson S, Whang JL, Harvey J, Agacki K, Patel H, Theodore J. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant. 1996 Feb;15(2):175–181. [PubMed]
  • Hasleton PS, Woodcock AA, Yonan N, Deiraniya AK. Should cryptogenic organizing pneumonia be included in the classification of pulmonary allograft rejection? J Heart Lung Transplant. 1996 Dec;15(12):1268–1269. [PubMed]
  • Elborn JS, Shale DJ, Britton JR. Heart-lung transplantation in cystic fibrosis: predictions for the next decade in England and Wales. Respir Med. 1994 Feb;88(2):135–138. [PubMed]
  • Egan JJ, Webb K, Woodcock AA. Lung donors for cystic fibrosis patients. Thorax. 1996 Aug;51(8):873–873. [PMC free article] [PubMed]
  • Wight C, Cohen B. Shortage of organs for transplantation. BMJ. 1996 Apr 20;312(7037):989–990. [PMC free article] [PubMed]
  • Matesanz R, Miranda B, Felipe C. Organ procurement in Spain: impact of transplant coordination. Clin Transplant. 1994 Jun;8(3 Pt 1):281–286. [PubMed]
  • Barr ML, Schenkel FA, Cohen RG, Chan KM, Barbers RG, Marboe CC, Starnes VA. Living-related lobar transplantation: recipient outcome and early rejection patterns. Transplant Proc. 1995 Jun;27(3):1995–1996. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press